Molsidomin and intraocular pressure. No effect in healthy subjects and in glaucoma patients

Leydhecker, W.

Fortschritte der Medizin 96(44): 2264-2265

1978


ISSN/ISBN: 0015-8178
PMID: 101432
Document Number: 135141
Molsidomine is a new agent in coronary therapy. It does not influence the intra-ocular pressure in healthy volunteers or in glaucoma patients. This was tested in double-blind studies in short trials and in a long term study of 3 months. The outflow facility or the visual fields were also unchanged. These results correspond closely to those obtained previously with other coronary therapeutics. Molsidomine is not dangerous for glaucoma patients.

Document emailed within 1 workday
Secure & encrypted payments